TrialSafety and Efficacy Study of PTG-100 in the Treatment of Moderate to Severe Ulcerative Colitis
Trial details
- Registry ID
- NCT02895100
- Phase
- Phase 2
PTGX
Protagonist Therapeutics, Inc.
Company identity checked against sources
Browse linked trials and recorded changes, or follow this company for updates.
6Trials in this database
0Recorded changes · last 12 months
Partial coverageOnly the trials and history collected so far
Research sample: selected versions from May 2023 onward plus a preceding baseline where available. Only selected fields were retained; endpoint measures were truncated to 300 characters. This is not complete trial or sponsor history. Daily snapshots begin when collection starts.
Completion dates · Pro
Which trial dates moved later?
Pro summarizes how far estimated completion dates moved later and counts trials with edits to their main study measures, using the history available here. View Pro features
Included trials
Check company identity source| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Safety and Efficacy Study of PTG-100 in the Treatment of Moderate to Severe Ulcerative ColitisNCT02895100 | PTGX | Phase 2 | Terminated | 2018-03-26Actual |
| Hepcidin Mimetic in Patients With Polycythemia Vera (REVIVE)NCT04057040 | PTGX | Phase 2 | Completed | 2023-02-14Actual |
| PTG-300 in Subjects With Hereditary HemochromatosisNCT04202965 | PTGX | Phase 2 | Completed | 2021-10-06Actual |
| PTG-300 in Patients With Polycythemia Vera and Elevated HematocritNCT04767802 | PTGX | Phase 2 | Completed | 2023-03-15Actual |
| A Phase 3 Study of Rusfertide in Patients With Polycythemia VeraNCT05210790 | PTGX | Phase 3 | Active not recruiting | 2025-02-21Actual |
| Study to Evaluate the Long-term Safety of Rusfertide (PTG-300) in Subjects With Polycythemia VeraNCT06033586 | PTGX | Phase 3 | Active not recruiting | 2026-04-01Estimated |
Hepcidin Mimetic in Patients With Polycythemia Vera (REVIVE)
Trial details
- Registry ID
- NCT04057040
- Phase
- Phase 2
PTG-300 in Subjects With Hereditary Hemochromatosis
Trial details
- Registry ID
- NCT04202965
- Phase
- Phase 2
PTG-300 in Patients With Polycythemia Vera and Elevated Hematocrit
Trial details
- Registry ID
- NCT04767802
- Phase
- Phase 2
A Phase 3 Study of Rusfertide in Patients With Polycythemia Vera
Trial details
- Registry ID
- NCT05210790
- Phase
- Phase 3
Study to Evaluate the Long-term Safety of Rusfertide (PTG-300) in Subjects With Polycythemia Vera
Trial details
- Registry ID
- NCT06033586
- Phase
- Phase 3
Latest recorded trial changes
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.